These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16418422)

  • 21. [Safety of tiotropium therapy in chronic obstructive lung diseases (COPD)].
    Osztovits J; Fehér J
    Orv Hetil; 2010 May; 151(18):749-50. PubMed ID: 20410002
    [No Abstract]   [Full Text] [Related]  

  • 22. Bronchodilator safety in chronic obstructive pulmonary disease-reply.
    Stanbrook MB; Campitelli M; Gershon A
    JAMA Intern Med; 2014 Apr; 174(4):648. PubMed ID: 24711200
    [No Abstract]   [Full Text] [Related]  

  • 23. Bronchodilator safety in chronic obstructive pulmonary disease: time to focus?
    van Dijk WD; Käyser SC
    JAMA Intern Med; 2014 Apr; 174(4):647. PubMed ID: 24711198
    [No Abstract]   [Full Text] [Related]  

  • 24. Sequential comparison of tiotropium to high-dose ipratropium in patients with chronic obstructive pulmonary disease in a practice setting.
    Gauhar U; Dransfield M; Cooper JA
    Int J Chron Obstruct Pulmon Dis; 2009; 4():391-5. PubMed ID: 19888357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Other forms of bronchodilation].
    Izquierdo Alonso JL; Malo de Molina R
    Arch Bronconeumol; 2004 Mar; 40 Suppl 1():23-9. PubMed ID: 16137446
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhaled tiotropium bromide and risk of stroke.
    Grosso A; Douglas I; Hingorani AD; MacAllister R; Hubbard R; Smeeth L
    Br J Clin Pharmacol; 2009 Nov; 68(5):731-6. PubMed ID: 19916997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease.
    Rau-Berger H; Mitfessel H; Glaab T
    Int J Chron Obstruct Pulmon Dis; 2010 Oct; 5():367-73. PubMed ID: 21103403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group.
    van Noord JA; Bantje TA; Eland ME; Korducki L; Cornelissen PJ
    Thorax; 2000 Apr; 55(4):289-94. PubMed ID: 10722768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease.
    Calverley PM; Lee A; Towse L; van Noord J; Witek TJ; Kelsen S
    Thorax; 2003 Oct; 58(10):855-60. PubMed ID: 14514937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anticholinergics and their cardiovascular effects--between fear and reality].
    Mihălţan F; Ulmeanu R
    Pneumologia; 2010; 59(2):107-8. PubMed ID: 20695368
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety, tolerability and risk benefit analysis of tiotropium in COPD.
    Oba Y; Zaza T; Thameem DM
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):575-84. PubMed ID: 19281075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of short-acting bronchodilators added to maintenance tiotropium therapy.
    Kerstjens HA; Bantje TA; Luursema PB; Sinninghe Damste HE; de Jong JW; Lee A; Wijker SP; Cornelissen PJ
    Chest; 2007 Nov; 132(5):1493-9. PubMed ID: 17890476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. More than just reassurance on tiotropium safety.
    Jenkins CR
    N Engl J Med; 2013 Oct; 369(16):1555-6. PubMed ID: 24131181
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a randomized, double-blind, double-dummy, efficacy and safety study in patients with chronic obstructive pulmonary disease].
    Zheng JP; Kang J; Cai BQ; Zhou X; Cao ZL; Bai CX; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):363-7. PubMed ID: 17045014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical benefits of tiotropium, a new anticholinergic bronchodilator].
    Izquierdo Alonso JL
    An Med Interna; 2002 Dec; 19(12):640-3. PubMed ID: 12593035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outpatient management of severe COPD.
    Singh S; Loke YK; Furberg CD
    N Engl J Med; 2010 Jul; 363(5):493-4; author reply 494-5. PubMed ID: 20666630
    [No Abstract]   [Full Text] [Related]  

  • 37. [The first long-acting anticholinergic drug. COPD drug with 24-hour effect].
    MMW Fortschr Med; 2002 Jun; 144(26):52. PubMed ID: 12154479
    [No Abstract]   [Full Text] [Related]  

  • 38. [Not Available].
    Kasak V
    Vnitr Lek; 2013 Dec; 59(12):1041-2. PubMed ID: 24466606
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of chronic obstructive pulmonary disease.
    Barr RG
    JAMA; 2004 Mar; 291(9):1066-7; author reply 1067. PubMed ID: 14996770
    [No Abstract]   [Full Text] [Related]  

  • 40. Managing chronic diseases: combination of inhaler treatment in India has shown good results.
    Koul PA
    BMJ; 2005 Apr; 330(7497):964; discussion 964-5. PubMed ID: 15845987
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.